Literature DB >> 90059

Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture.

J Uitto, E A Bauer, A Z Eisen.   

Abstract

To assess potential abnormalities in collagen metabolism in systemic scleroderma, skin fibroblast lines from patients with this disease were established and compared to control cell lines derived from healthy subjects. For studies on the biosynthesis of procollagen, the cells were incubated with [(14)C]proline in a medium supplemented with ascorbic acid and beta-aminopropionitrile, and the synthesis of nondialyzable [(14)C]hydroxyproline, in relation to DNA or cell protein, was taken as an index of procollagen formation. Five of eight scleroderma fibroblast cell lines demonstrated procollagen biosynthesis rates significantly higher than the controls, and the mean rate of procollagen synthesis by scleroderma fibroblasts was about twice that of the control cells. Control experiments demonstrated that the specific activity of the intracellular free proline was not different in scleroderma and control fibroblasts, and the mean population doubling times of the scleroderma and the control fibroblast cell lines were the same. The relative synthesis of the genetically distinct procollagens was examined by isolating type I and type III procollagens from the cell culture medium using DEAE-cellulose chromatography. The ratios of type I/III procollagens in scleroderma cell lines did not differ from the controls. The helical stability of the collagenous portion of type I and type III procollagens, estimated by the resistance of (14)C-collagen to limited proteolytic digestion with pepsin under nondenaturing conditions, was the same in both scleroderma and control cultures. The capacity of the cells to synthesize enzymatically active and immunologically reacting collagenase was also studied; no marked differences in these parameters could be observed. The results suggest that cultured skin fibroblasts from patients with scleroderma demonstrate a metabolic abnormality expressed as increased synthesis of type I and type III procollagens in a normal ratio. This abnormality may play a role in the excessive accumulation of collagen in the skin and other organs affected in scleroderma.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90059      PMCID: PMC372200          DOI: 10.1172/JCI109558

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Identification of the collagenous proteins synthesized by cultured cells from human skin.

Authors:  J R Lichtenstein; P H Byers; B D Smith; G R Martin
Journal:  Biochemistry       Date:  1975-04-22       Impact factor: 3.162

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  A photometric method for the determination of proline.

Authors:  W TROLL; J LINDSLEY
Journal:  J Biol Chem       Date:  1955-08       Impact factor: 5.157

4.  Collagenase production by human skin fibroblasts.

Authors:  E A Bauer; G P Stricklin; J J Jeffrey; A Z Eisen
Journal:  Biochem Biophys Res Commun       Date:  1975-05-05       Impact factor: 3.575

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Characterization of procollagen synthesized by matrix-free cells isolated from chick embryo tendons.

Authors:  J Uitto; J R Lichtenstein; E A Bauer
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

7.  Human skin fibroblast collagenase: chemical properties of precursor and active forms.

Authors:  G P Stricklin; A Z Eisen; E A Bauer; J J Jeffrey
Journal:  Biochemistry       Date:  1978-06-13       Impact factor: 3.162

8.  Collagenase in scleroderma.

Authors:  A H Brady
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

9.  Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures.

Authors:  G P Stricklin; E A Bauer; J J Jeffrey; A Z Eisen
Journal:  Biochemistry       Date:  1977-04-19       Impact factor: 3.162

10.  Fetal membrane collagens: identification of two new collagen alpha chains.

Authors:  R E Burgeson; F A El Adli; I I Kaitila; D W Hollister
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

View more
  42 in total

1.  Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis.

Authors:  Camilo S Zurita-Salinas; Edgar Krötzsch; Lino Díaz de León; Jorge Alcocer-Varela
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

2.  Collagen biosynthesis and type I and type III procollagen mRNA in lichen sclerosus et atrophicus.

Authors:  R Panizzon; T Vuorio; L Bruckner-Tuderman
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients.

Authors:  Manuela Indelicato; Valentina Chiarenza; Massimo Libra; Grazia Malaponte; Valentina Bevelacqua; Maurizio Marchini; James A McCubrey; Franca Stivala; Raffaella Scorza; Maria Clorinda Mazzarino
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

4.  Response of scleroderma fibroblasts to various growth factors.

Authors:  K Takehara; Y Soma; A Igarashi; K Kikuchi; A Moro; Y Ishibashi
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

5.  Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.

Authors:  S R Goldring; M L Stephenson; E Downie; S M Krane; J H Korn
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  From the bench to the bedside and back: an essential journey.

Authors:  Eugene A Bauer
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

7.  Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma.

Authors:  M R Duncan; B Berman
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 8.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

9.  Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts.

Authors:  T Vuorio; J K Mäkelä; V M Kähäri; E Vuorio
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

10.  Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures.

Authors:  K Takeda; A Hatamochi; M Arakawa; H Ueki
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.